Business
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Hi, what are you looking for?
Jewish Business News
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
XIO is paying a 16% premium on the share price of the Israeli medical device company.
Business
Frutarom Industries Ltd. continues implementing its rapid growth strategy, which made it one of the world’s 10 largest companies in the field of flavors...
Business
Allergan PLC, the Botox maker to treat wrinkles, agreed to buy Kythera Biopharmaceuticals Inc.,
Business
NCR stock jumped 13% on the revelation.
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Business
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
Business
UK hedge fund Odey Asset Management, which has a 25.5% holding in Plus500, opposes Teddy Sagi's offer.